Osteopore Limited (ASX:OSX)
Australia · Delayed Price · Currency is AUD 0.0040
0.00 (0.00%)
Sep 11, 2026, 10:02 AM AEST
Osteopore Income Statement
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2.93 | 3.06 | 2.76 | 2.22 | 1.69 | 1.11 | |
Revenue Growth | 2.86% | 10.65% | 24.59% | 31.02% | 52.05% | -26.02% |
Cost of Revenue | 0.57 | 0.69 | 0.47 | 0.58 | 0.42 | 0.3 |
Gross Profit | 2.36 | 2.37 | 2.3 | 1.64 | 1.27 | 0.81 |
Selling, General & Admin | 3.4 | 3.44 | 3.51 | 4.06 | 3.86 | 4.71 |
Research & Development | 1.68 | 1.45 | 1.14 | 1.57 | 1.43 | - |
Other Operating Expenses | 0.62 | 0.65 | 0.42 | 0.29 | 0.18 | -0.29 |
Operating Expenses | 5.83 | 5.69 | 5.24 | 6.46 | 5.47 | 4.42 |
Operating Income | -3.47 | -3.32 | -2.94 | -4.82 | -4.19 | -3.6 |
Interest Expense | -0.3 | -0.28 | -0.43 | -0.02 | -0.01 | -0.02 |
Interest & Investment Income | 0.01 | 0 | 0 | 0.01 | 0.01 | - |
Other Non Operating Income (Expenses) | -0.04 | -0.03 | - | - | - | - |
EBT Excluding Unusual Items | -3.86 | -3.63 | -3.37 | -4.83 | -4.2 | -3.62 |
Asset Writedown | -0.09 | -0.09 | - | - | - | - |
Pretax Income | -3.95 | -3.72 | -3.33 | -4.83 | -4.2 | -3.62 |
Income Tax Expense | 0.02 | 0 | 0.02 | 0.04 | - | - |
Net Income | -3.97 | -3.72 | -3.35 | -4.87 | -4.2 | -3.62 |
Net Income to Common | -3.97 | -3.72 | -3.35 | -4.87 | -4.2 | -3.62 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 383 | 188 | 78 | 10 | 8 | 8 |
Shares Outstanding (Diluted) | 383 | 188 | 78 | 10 | 8 | 8 |
Shares Change | 322.18% | 140.65% | 719.13% | 16.00% | 5.37% | 9.90% |
EPS (Basic) | -0.01 | -0.02 | -0.04 | -0.51 | -0.51 | -0.46 |
EPS (Diluted) | -0.01 | -0.02 | -0.04 | -0.51 | -0.51 | -0.46 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -2.19 | -2.55 | -3.1 | -3.73 | -4.06 | -4 |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.04 | -0.39 | -0.49 | -0.51 |
Gross Margin | 80.64% | 77.51% | 83.08% | 73.78% | 75.24% | 72.92% |
Operating Margin | -118.62% | -108.66% | -106.57% | -217.41% | -247.70% | -323.86% |
Profit Margin | -135.81% | -121.76% | -121.34% | -219.72% | -247.89% | -325.32% |
Free Cash Flow Margin | -74.97% | -83.47% | -112.30% | -168.19% | -239.74% | -359.41% |
EBITDA | -3.22 | -2.85 | -2.47 | -4.4 | -4.02 | -3.42 |
EBITDA Margin | -109.92% | -93.33% | -89.23% | -198.47% | -237.25% | - |
D&A For EBITDA | 0.25 | 0.47 | 0.48 | 0.42 | 0.18 | 0.18 |
EBIT | -3.47 | -3.32 | -2.94 | -4.82 | -4.19 | -3.6 |
EBIT Margin | -118.62% | -108.66% | -106.57% | -217.41% | -247.70% | - |